Although we observed significantly higher MDM2 levels in quiescent compared to proliferating CD34+ cells, we found lower, rather than higher, sensitivity of quiescent CD34+ CML cells to nutlin3a, compared to proliferating cells. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.